[Therapy-induced tumor regression. Morphological findings in malignant primary and secondary liver tumors following intensive regional cytostatic treatment].
D000230:Adenocarcinoma / Q000473:pathology / Q000556:secondary; D002276:Carcinoid Tumor / Q000473:pathology / Q000556:secondary; D010478:Chemotherapy, Cancer, Regional Perfusion; D003110:Colonic Neoplasms / Q000473:pathology*; D004317:Doxorubicin / Q000627:therapeutic use; D004621:Embolization, Therapeutic; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D007269:Injections, Intra-Arterial; D008099:Liver / Q000473:pathology; D008113:Liver Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary*; D008937:Mitomycins / Q000627:therapeutic use; D009336:Necrosis; D012004:Rectal Neoplasms / Q000473:pathology*
D008937:Mitomycins; D004317:Doxorubicin; D005472:Fluorouracil
Therapieinduzierte Tumorregression. Morphologische Befunde an malignen primären und sekundären Lebertumoren nach hochdosierter regionaler Zytostase.